Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease.
about
New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase.pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics.Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis.
P2860
Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Discovery of AZD2716: A Novel ...... nt of Coronary Artery Disease.
@en
Discovery of AZD2716: A Novel Secreted Phospholipase A2
@nl
type
label
Discovery of AZD2716: A Novel ...... nt of Coronary Artery Disease.
@en
Discovery of AZD2716: A Novel Secreted Phospholipase A2
@nl
prefLabel
Discovery of AZD2716: A Novel ...... nt of Coronary Artery Disease.
@en
Discovery of AZD2716: A Novel Secreted Phospholipase A2
@nl
P2093
P2860
P1476
Discovery of AZD2716: A Novel ...... nt of Coronary Artery Disease.
@en
P2093
Birgitta Rosengren
Daniel Pettersen
Eva Hurt-Camejo
Fabrizio Giordanetto
Ingemar Starke
Jenny Sandmark
Lars-Olof Larsson
Laurent Knerr
Marie Castaldo
Mikael Dahlström
P2860
P304
P356
10.1021/ACSMEDCHEMLETT.6B00188
P577
2016-08-09T00:00:00Z